Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7427-7443

  Lynn, Helena ^a   Horsington, Jacquelyn ^a   Ter, Lee Kuan ^b   Han, Shuyi ^a   Chew, Yee Lian ^a   Diefenbach, Russell J ^a   Way, Michael ^c   Chaudhri, Geeta ^b   Karupiah, Gunasegaran ^b   Newsome, Timothy P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Biology and Environment   (Australia)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN A36; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

A36R GENE; ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LOSS; CONTROLLED STUDY; EMBRYO; FEMALE; GENE DELETION; GENE FUNCTION; IN VIVO STUDY; INFECTION SENSITIVITY; INTRACELLULAR TRANSPORT; LIVER EXAMINATION; LYMPH NODE; MICROTUBULE; MOUSE; MOUSEPOX; NONHUMAN; PHENOTYPE; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN EXAMINATION; VACCINIA VIRUS; VIRUS CONCENTRATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS MUTANT; VIRUS PLAQUE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

ANIMALS; CYTOSKELETAL PROTEINS; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; FEMALE; GENE DELETION; HOST-PATHOGEN INTERACTIONS; LIVER; LYMPH NODES; MICE; MICE, INBRED BALB C; PROTEIN TRANSPORT; SPLEEN; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRAL PROTEINS; VIRULENCE; VIRUS RELEASE;

ECTROMELIA VIRUS; MUS; ORTHOPOXVIRUS; VACCINIA VIRUS;

EID: 84864125036     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06636-11     Document Type: Article

References (80)

1. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M. 2007. The release of vaccinia from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1:227-240.
2. Boratynska A, et al. 2010. Contribution of rearranged actin structures to the spread of ectromelia virus infection in vitro. Acta Virol. 54:41- 48.
3. Buller RM. 2004. Mousepox: a small animal model for biodefense research. Appl. Biosaf. 9:10 -19.
4. Butler-Cole C, et al. 2007. An ectromelia virus profilin homolog interacts with cellular tropomyosin and viral A-type inclusion protein. Virol. J. 4:76.
5. Chakrabarti S, Sisler JR, Moss B. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23:1094- 1097.
6. Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G. 2006. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J. Virol. 80:6339-6344.
7. Chaudhri G, et al. 2004. Polarized type 1 cytokine response and cellmediated immunity determine genetic resistance to mousepox. Proc. Natl. Acad. Sci. U. S. A. 101:9057-9062.
8. Chen N, et al. 2003. The genomic sequence of ectromelia virus, the causative agent of mousepox. Virology 317:165-186.
9. Cudmore S, Cossart P, Griffiths G, Way M. 1995. Actin-based motility of vaccinia virus. Nature 378:636-638.
10. Desai P, Sexton GL, McCaffery JM, Person S. 2001. A null mutation in the gene encoding the herpes simplex virus type 1 UL37 polypeptide abrogates virus maturation. J. Virol. 75:10259 -10271.
11. Desai PJ. 2000. A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells. J. Virol. 74:11608 -11618.
12. Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL. 2008. Transport and egress of herpes simplex virus in neurons. Rev. Med. Virol. 18:35-51.
13. Doceul V, Hollinshead M, van der Linden L, Smith GL. 2010. Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327:873- 876.
14. Dodding M, Newsome TP, Collinson L, Edwards C, Way M. 2009. An E2-F12 complex is required for IEV morphogenesis during vaccinia infection. Cell. Microbiol. 11:808-824.
15. Dodding MP, Mitter R, Humphries AC, Way M. 2011. A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. EMBO J. 30:4523- 4538.
16. Dodding MP, Way M. 2011. Coupling viruses to dynein and kinesin-1. EMBO J. 30:3527-3539.
17. Dodding MP, Way M. 2009. Nck- and N-WASP-dependent actin-based motility is conserved in divergent vertebrate poxviruses. Cell Host Microbe 6:536 -550.
18. Dohner K, Nagel CH, Sodeik B. 2005. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins. Trends Microbiol. 13:320- 327.
19. Duteyrat JL, Gelfi J, Bertagnoli S. 2006. Ultrastructural study of myxoma virus morphogenesis. Arch. Virol. 151:2161-2180.
20. Edghill-Smith Y, et al. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11:740 -747.
21. Engelstad M, Smith GL. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627- 637.
22. Erez N, et al. 2009. Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex. Virol. J. 6:151.
23. Esteban DJ, Buller RM. 2005. Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86:2645-2659.
24. Fang M, Lanier LL, Sigal LJ. 2008. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 4:e30. doi:10.1371/journal.ppat.0040030.
25. Frischknecht F, et al. 1999. Tyrosine phosphorylation is required for actin-based motility of vaccinia but not Listeria or Shigella. Curr. Biol. 9:89 -92.
26. Frischknecht F, et al. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926 -929.
27. Geada MM, Galindo I, Lorenzo MM, Perdiguero B, Blasco R. 2001. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J. Gen. Virol. 82:2747-2760.
28. Goley ED, et al. 2006. Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like protein. Science 314:464-467.
29. Greber UF, Way M. 2006. A superhighway to virus infection. Cell 124: 741-754.
30. Grenklo S, et al. 2003. A crucial role for profilin-actin in the intracellular motility of Listeria monocytogenes. EMBO Rep. 4:523-529.
31. Herrero-Martinez E, Roberts KL, Hollinshead M, Smith GL. 2005. Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J. Gen. Virol. 86: 2961-2968.
32. Hollinshead M, et al. 2001. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 154:389-402.
33. Hollinshead M, Vanderplasschen A, Smith GL, Vaux DJ. 1999. Vaccinia virus intracellular mature virions contain only one lipid membrane. J. Virol. 73:1503-1517.
34. Huang J, et al. 2004. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J. Biol. Chem. 279:54110 -54116.
35. Johnston SC, Ward BM. 2009. The vaccinia virus protein F12 associates with IEV through an interaction with A36. J. Virol. 83:1708 -1717.
36. Karupiah G, Buller RM, Van Rooijen N, Duarte CJ, Chen J. 1996. Different roles for CD4 and CD8 T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301- 8309.
37. Law M, Hollinshead M, Lee HJ, Smith GL. 2004. Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J. Gen. Virol. 85:1279 -1290.
38. McIntosh AA, Smith GL. 1996. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70:272- 281.
39. Mombaerts P, et al. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
40. Moreau V, et al. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2:441- 448.
41. Morgan GW, et al. 2010. Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog. 6:e1000785.
42. Moss B, Shisler JL. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:59-66.
43. Newsome TP, Scaplehorn N, Way M. 2004. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306:124- 129.
44. Newsome TP, Weisswange I, Frischknecht F, Way M. 2006. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Cell. Microbiol. 8:233-241.
45. Ohkawa T, Volkman LE, Welch MD. 2010. Actin-based motility drives baculovirus transit to the nucleus and cell surface. J. Cell Biol. 190:187- 195.
46. Panchanathan V, Chaudhri G, Karupiah G. 2008. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86:80-86.
47. Panchanathan V, Chaudhri G, Karupiah G. 2005. Interferon function is not required for recovery from a secondary poxvirus infection. Proc. Natl. Acad. Sci. U. S. A. 102:12921-12926.
48. Panchanathan V, Chaudhri G, Karupiah G. 2006. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J. Virol. 80:6333- 6338.
49. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM. 2007. Induction of natural killer cell responses by ectromelia virus controls infection. J. Virol. 81:4070-4079.
50. Parker S, et al. 2009. Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies. Virology 385:11-21.
51. Parkinson JE, Smith GL. 1994. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204:376 -390.
52. Pulford DJ, Meyer H, Ulaeto D. 2002. Orthologs of the vaccinia A13L and A36R virion membrane protein genes display diversity in species of the genus Orthopoxvirus. Arch. Virol. 147:995-1015.
53. Radtke K, et al. 2010. Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS Pathog. 6:e1000991. doi:10.1371/journal.ppat.1000991.
54. Reeves PM, et al. 2005. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11:731-739. (Erratum, 11:1361.)
55. Reeves PM, et al. 2011. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on Abl and SRC family tyrosine kinases. J. Virol. 85:21-31.
56. Riedl J, et al. 2008. Lifeact: a versatile marker to visualize F-actin. Nat. Methods 5:605- 607.
57. Rietdorf J, et al. 2001. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 3:992-1000.
58. Roberts KL, Smith GL. 2008. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 16:472- 479.
59. Reference deleted
60. Rottger S, Frischknecht F, Reckmann I, Smith GL, Way M. 1999. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:2863-2875.
61. Sakala IG, et al. 2007. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J. Virol. 81:3346- 3353.
62. Sanderson CM, Hollinshead M, Smith GL. 2000. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J. Gen. Virol. 81:47-58.
63. Sathish N, Zhu FX, Yuan Y. 2009. Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules. PLoS Pathog. 5:e1000332. doi:10.1371/journal.ppat.1000332.
64. Scaplehorn N, et al. 2002. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 12:740 -745.
65. Schepis A, Stauber T, Krijnse Locker J. 2007. Kinesin-1 plays multiple roles during the vaccinia virus life cycle. Cell. Microbiol. 9:1960 -1973.
66. Seet BT, et al. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377- 423.
67. Smith GL, Symons JA, Khanna A, Vanderplasschen A, Alcami A. 1997. Vaccinia virus immune evasion. Immunol. Rev. 159:137-154.
68. Snapper SB, et al. 2001. N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat. Cell Biol. 3:897-904.
69. Sodeik B. 2000. Mechanisms of viral transport in the cytoplasm. Trends Microbiol. 8:465- 472.
70. Taylor MP, Koyuncu OO, Enquist LW. 2011. Subversion of the actin cytoskeleton during viral infection. Nat. Rev. Microbiol. 9:427- 439.
71. Tscharke DC, Reading PC, Smith GL. 2002. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J. Gen. Virol. 83:1977-1986.
72. van Eijl H, Hollinshead M, Rodger G, Zhang WH, Smith GL. 2002. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 83:195-207.
73. van Eijl H, Hollinshead M, Smith GL. 2000. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271:26 -36.
74. Ward BM, Moss B. 2004. Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. J. Virol. 78:2486 -2493.
75. Ward BM, Moss B. 2001. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 75: 11651-11663.
76. Ward BM, Moss B. 2001. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 75:4802- 4813.
77. Weisswange I, Newsome TP, Schleich S, Way M. 2009. The rate of N-WASP exchange limits the extent of Arp2/3 complex dependent actinbased motility. Nature 458:87-91.
78. Wilton BA, et al. 2008. Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases. Virology 374: 82-99.
79. Xu RH, et al. 2008. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J. Exp. Med. 205:981-992.
80. Zhu FX, Li X, Zhou F, Gao SJ, Yuan Y. 2006. Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis. J. Virol. 80:12187-12196.